## Objective: To compare the prevalence of fatigue in patients with parkinson's disease (pd) with that in healthy elderly people and to explore the suggestion that fatigue is an independent symptom of pd. ## Design: Questionnaire survey. ## Setting: Community-based population. ## Patients and
Fatigue in Japanese patients with Parkinson's disease: A study using Parkinson fatigue scale
✍ Scribed by Yasuyuki Okuma; Satoshi Kamei; Akihiko Morita; Fumihito Yoshii; Toshimasa Yamamoto; Shiori Hashimoto; Hiroya Utsumi; Taku Hatano; Nobutaka Hattori; Miyuki Matsumura; Kazushi Takahashi; Shigeru Nogawa; Yuka Watanabe; Tomoyuki Miyamoto; Masayuki Miyamoto; Koichi Hirata
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 76 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The objective of this multicenter cross‐sectional study was to determine the prevalence of fatigue and factors contributing to it in a large sample of Japanese patients with Parkinson's disease (PD). We used the 16‐item Parkinson Fatigue Scale (PFS‐16), which was designed to assess fatigue exclusively associated with PD. We carried out this study using PFS‐16, the Unified Parkinson's Disease Rating Scale, Zung's Self‐Rating Depression Scale, Parkinson's Disease Sleep Scale (PDSS), and the PD quality of life (QOL) scale (PDQ‐39) by interview using questionnaires and physical examination by neurologists in 361 nondemented PD patients. Fatigue (an average PFS score of 3.3 or greater) was revealed in 151 patients (41.8%). Multiple logistic regression analysis indicated that the significant independent variables related to the presence of fatigue were the scores of PDSS and PDQ‐39. Depression score was not a significant contributing factor. Our study revealed that the prevalence of fatigue in Japanese PD patients is as high as that in Western countries, and that fatigue is a relatively independent symptom, although sleep disturbance may be associated with fatigue. Since fatigue is significantly related to QOL reduction, therapeutic interventions including treatment of sleep disturbance are important. © 2009 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The present multicenter cross‐sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data
## Abstract Fatigue is a common problem in Parkinson's disease (PD), often the most troubling of all symptoms. It is poorly understood, generally under‐recognized, and has no known treatment. This article reviews what is known about the symptom, putting it into the context of fatigue in other disor
## Abstract ## Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. ## Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the prev
## Abstract Fatigue affects about 50% of Parkinson's disease (PD) patients and is frequently one of its most disabling aspects. It does not correlate with disease severity or duration but does correlate with depression. Fatigue and depression are distinct symptoms and fatigue often fails to respond
## Abstract We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double‐blind, placebo‐controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Vi